Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03690999 · ClinicalTrials.gov registry record · NA

The RAMP Study - Rejuvenation of the Aging Microbiota With Prebiotics

A NA study, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
98
Enrollment target

NCT03690999: Completed NA study, sponsored by Stanford University.

NCT03690999 is a NA study that has completed, run by Stanford University. The registered enrollment target is 98 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03690999, a NA study, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
98 participants
Enrollment target

Study Summary

An individual's immune and metabolic status is coupled to consumed carbohydrates. Complex carbohydrates that are not digested by human enzymes may influence host biology by impacting microbiota composition and function, or act in a yet-unknown microbiota-independent manner. Prebiotics offer a promising safe route to influence host health, possibly via the microbiota. However, it remains largely unknown to what extent immune function and metabolism can be modulated by prebiotics.

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Prebiotic supplement

Trial Details

FieldValue
Enrollment Target 98 participants
Start Date 2019-03-14
Est. Completion 2020-12-14
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT03690999

The ClinicalTrials.gov registry entry for NCT03690999 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT03690999 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03690999 about?

NCT03690999 is a clinical study titled "The RAMP Study - Rejuvenation of the Aging Microbiota With Prebiotics". An individual's immune and metabolic status is coupled to consumed carbohydrates. Complex carbohydrates that are not digested by human enzymes may influence host biology by impacting microbiota composition and function, or act in a yet-unknown microbiota-independent manner. Prebiotics offer a promis...

What is the current status of trial NCT03690999?

This trial is currently completed. It is a NA study. The enrollment target is 98 participants. The study started on 2019-03-14. Estimated completion is 2020-12-14.

What interventions are being tested in trial NCT03690999?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Prebiotic supplement (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03690999?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.